Pregnancy transforms nearly every system in a woman’s body, yet the specificity and timing of these changes remain poorly understood. To help fill that gap, scientists from Oura’s science team recently published one of the largest longitudinal analyses of its kind, using real-world data from more than 10,000 pregnancies tracked […]
Research/Studies
Why Night Guards Aren’t Enough: Addressing the Neurological Roots of Sleep Bruxism with Biofeedback
For millions of people, the sound of teeth grinding is more than an annoyance—it’s a nightly neuromuscular storm. Sleep bruxism, characterized by involuntary clenching and grinding of the jaw during sleep, affects an estimated 8%–15% of adults worldwide.¹ Dentists have long turned to night guards as the standard solution, shielding […]
Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings
Inspire Medical Systems, Inc. published Inspire V clinical outcomes data from its Singapore clinical study, as well as the Company’s limited market release in the United States, including single-site experience at two leading centers. These data will be presented at the American Otolaryngology-Head and Neck Surgery (AAO-HNS) and International Surgical […]
BetterNight Acquires Coastal and Epoch Sleep Centers to Expand National Sleep Health Services
BetterNight, a national leader in comprehensive sleep health solutions, announced the acquisition of Coastal Sleep Diagnostics and Epoch Sleep Centers, two well-established sleep care providers serving communities across the Northeastern United States. The acquisition marks a significant milestone in BetterNight’s mission to improve sleep health outcomes through innovation, personalized care, […]
NOCTEM Health
An estimated one in three adults worldwide experience symptoms of insomnia, yet only a fraction of those suffering have access to specialists trained in cognitive behavioral therapy for insomnia (CBTI)—the gold standard in treatment.1,2 This unmet need has created a major bottleneck in behavioral sleep medicine, where demand far exceeds […]
Specific Gut Bacteria Linked to Insomnia
Specific types of gut bacteria may increase or decrease the risk for insomnia, while insomnia itself may in turn alter the abundance of certain gut bacteria, a new study showed. However, outside experts challenged the investigators’ assertion that the link is causal. Investigators identified 14 groups of bacteria associated with increased […]
More Than a Number: Sleep Quality Is the Next Target for Cardiovascular Health
From the Dalai Lama’s claim that it is the “best meditation” to Benjamin Franklin’s insistence that it makes a person “healthy, wealthy, and wise,” a good night’s sleep has long been touted as the secret to a healthy life. And the American Heart Association (AHA) agrees. In 2022, the AHA added sleep […]
Poor Sleep Quality May Worsen Emotional Burden in T2D
Topline: Patients with type 2 diabetes (T2D) who experienced sleep impairments, including short sleep duration, snoring, and insomnia symptoms, were more likely to face an increased risk for diabetes distress. In particular, daytime coping difficulties due to sleep problems showed a notably prominent association with diabetes distress. Methodology: Researchers in Norway conducted a cross-sectional […]
Illuminating Narcolepsy’s Neural Pathways
Sleep and wakefulness are carefully balanced by a network of brain regions. Yet for many years, scientists couldn’t pinpoint exactly which neurons regulated sleep state transitions. New research tools and a deeper understanding of brain signaling have led to new discoveries in dopamine and norepinephrine signaling, offering novel insights into […]
Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1
Alkermes plc today announced positive topline results from the randomized double-blind treatment period of the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 (NT1). Alixorexton, formerly referred to as ALKS 2680, is the company’s novel, investigational, oral orexin 2 receptor (OX2R) agonist in phase 2 development as […]













